MARIA ANGELES
SOLINIS ASPIAZU
PROFESORADO TITULAR DE UNIVERSIDAD
Publicaciones en las que colabora con MARIA ANGELES SOLINIS ASPIAZU (31)
2023
-
Modelo SoTL para evaluar el aprendizaje basado en la investigación en el desarrollo de TFG sobre atención farmacéutica
XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones
2021
-
Investigación sobre servicios profesionales farmacéuticos asistenciales en el marco de los trabajos fin de grado desarrollados durante las prácticas tuteladas
RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 248-250
2011
-
Novel extended-release formulation of lovastatin by one-step melt granulation: In vitro and in vivo evaluation
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 77, Núm. 2, pp. 306-312
2010
-
In vivo evaluation of two new sustained release formulations elaborated by one-step melt granulation: Level A in vitro-in vivo correlation
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 75, Núm. 2, pp. 232-237
-
Solid lipid nanoparticles as potential tools for gene therapy: In vivo protein expression after intravenous administration
International Journal of Pharmaceutics, Vol. 385, Núm. 1-2, pp. 157-162
2009
-
A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectors
Journal of Controlled Release, Vol. 133, Núm. 1, pp. 52-59
-
Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 71, Núm. 2, pp. 181-189
2008
-
Population pharmacokinetics of meropenem in critically ill patients undergoing continuous renal replacement therapy
Clinical Pharmacokinetics, Vol. 47, Núm. 3, pp. 173-180
-
Solid lipid nanoparticles for retinal gene therapy: Transfection and intracellular trafficking in RPE cells
International Journal of Pharmaceutics, Vol. 360, Núm. 1-2, pp. 177-183
2007
-
Solid lipid nanoparticles: Formulation factors affecting cell transfection capacity
International Journal of Pharmaceutics, Vol. 339, Núm. 1-2, pp. 261-268
2006
-
Terapia génica: concepto, sistemas de administración y aplicaciones
Industria farmacéutica: Equipos, procesos y tecnología, Núm. 128, pp. 86-99
2005
-
Análisis farmacocinético/farmacodinámico (PK/PD) de la antibioterapia en odontoestomatología
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 23, Núm. 3, pp. 116-121
-
Determination of ceftazidime and cefepime in plasma and dialysate-ultrafiltrate from patients undergoing continuous veno-venous hemodiafiltration by HPLC
Journal of Pharmaceutical and Biomedical Analysis, Vol. 39, Núm. 5, pp. 996-1005
-
Pharmacokinetic/pharmacodynamic evaluation of antimicrobial treatments of orofacial odontogenic infections
Clinical Pharmacokinetics, Vol. 44, Núm. 3, pp. 305-316
-
Quantification and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC
Biomedical Chromatography, Vol. 19, Núm. 8, pp. 570-578
2004
-
Bioequivalence of two oral ciprofloxacin tablets formulations
International Journal of Clinical Pharmacology and Therapeutics, Vol. 42, Núm. 6, pp. 336-341
2003
-
Comparative bioavailability of two immediate-release tablets of lisinopril/hydrochlorothiazide in healthy volunteers
International Journal of Clinical Pharmacology and Therapeutics, Vol. 41, Núm. 7, pp. 309-315
-
In vivo pharmacokinetic-pharmacodynamic relationship and in vitro equivalence of two oral furosemide tablet formulations
Arzneimittel-Forschung/Drug Research, Vol. 53, Núm. 5, pp. 321-329
-
Release of salbutamol enantiomers from HPMC matrices elaborated by wetgranulation
Congreso de la SEFIG (4º. Granada. 2003). 3as. Jornadas de Tecnología Farmacéutica
2002
-
Release of ketoprofen enantiomers from HPMC K100M matrices - Diffusion studies
International Journal of Pharmaceutics, Vol. 239, Núm. 1-2, pp. 61-68